| Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled … JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ... MedRxiv, 2020 | 175 | 2020 |
| Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis DR Morales, MM Conover, SC You, N Pratt, K Kostka, T Duarte-Salles, ... The Lancet Digital Health 3 (2), e98-e114, 2021 | 153 | 2021 |
| Importance of early precautionary actions in avoiding the spread of COVID-19: Saudi Arabia as an Example TM Alshammari, AF Altebainawi, KA Alenzi Saudi Pharmaceutical Journal 28 (7), 898-902, 2020 | 143 | 2020 |
| Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ... The Lancet Rheumatology 2 (11), e698-e711, 2020 | 134 | 2020 |
| Critical steps and energetics involved in a successful development of a stable nanoemulsion A Qadir, MD Faiyazuddin, MDT Hussain, TM Alshammari, F Shakeel Journal of Molecular Liquids 214, 7-18, 2016 | 127 | 2016 |
| Community pharmacists’ knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia MA Mahmoud, Y Alswaida, T Alshammari, TM Khan, A Alrasheedy, ... Saudi pharmaceutical journal 22 (5), 411-418, 2014 | 107 | 2014 |
| Health care professionals’ awareness of, knowledge about and attitude to influenza vaccination TM Alshammari, LS AlFehaid, JK AlFraih, HS Aljadhey Vaccine 32 (45), 5957-5961, 2014 | 94 | 2014 |
| Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study E Burn, SC You, AG Sena, K Kostka, H Abedtash, MTF Abrahao, ... Nature communications 11 (1), 5009, 2020 | 93 | 2020 |
| Drug safety: The concept, inception and its importance in patients’ health TM Alshammari Saudi Pharmaceutical Journal 24 (4), 405-412, 2016 | 83 | 2016 |
| Risk of hepatotoxicity associated with fluoroquinolones: a national case–control safety study TM Alshammari, EP Larrat, HJ Morrill, AR Caffrey, BJ Quilliam, ... American journal of health-system pharmacy 71 (1), 37-43, 2014 | 83 | 2014 |
| Healthcare professionals’ knowledge, attitude and acceptance of influenza vaccination in Saudi Arabia: a multicenter cross-sectional study TM Alshammari, KB Yusuff, MM Aziz, GM Subaie BMC health services research 19, 1-10, 2019 | 72 | 2019 |
| Knowledge, attitudes & practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: a multi-centre cross sectional study TM AlShammari, MJ Almoslem Saudi pharmaceutical journal 26 (7), 925-931, 2018 | 68 | 2018 |
| Parental perceptions, attitudes and acceptance of childhood immunization in Saudi Arabia: A cross sectional study TM Alshammari, GM Subaiea, T Hussain, A Moin, KB Yusuff Vaccine 36 (1), 23-28, 2018 | 67 | 2018 |
| Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia TM Alshammari, KK Alamri, YA Ghawa, NF Alohali, SA Abualkol, ... International journal of clinical pharmacy 37, 1104-1110, 2015 | 67 | 2015 |
| Energy drinks and population health: consumption pattern and adverse effects among Saudi population GM Subaiea, AF Altebainawi, TM Alshammari BMC Public Health 19, 1-12, 2019 | 66 | 2019 |
| Comparison of different serum sample extraction methods and their suitability for mass spectrometry analysis TM Alshammari, AA Al-Hassan, TB Hadda, M Aljofan Saudi pharmaceutical journal 23 (6), 689-697, 2015 | 65 | 2015 |
| Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study A Prats-Uribe, AG Sena, LYH Lai, H Alghoul, O Alser, TM Alshammari, ... bmj 373, 2021 | 64 | 2021 |
| The reporting of a disproportionality analysis for drug Safety signal detection using individual case safety reports in pharmacovigilance (READUS-PV): explanation and elaboration M Fusaroli, F Salvo, B Begaud, TM AlShammari, A Bate, V Battini, ... Drug safety 47 (6), 585-599, 2024 | 60 | 2024 |
| Pharmacovigilance system in Saudi Arabia TM Alshammari, M Alshakka, H Aljadhey Saudi pharmaceutical journal 25 (3), 299-305, 2017 | 58 | 2017 |
| Thirty-day outcomes of children and adolescents with COVID-19: an international experience T Duarte-Salles, D Vizcaya, A Pistillo, P Casajust, AG Sena, LYH Lai, ... Pediatrics 148 (3), 2021 | 57 | 2021 |
